Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Karen L Price"'
Autor:
Daniyal J Jafree, Dale Moulding, Maria Kolatsi-Joannou, Nuria Perretta Tejedor, Karen L Price, Natalie J Milmoe, Claire L Walsh, Rosa Maria Correra, Paul JD Winyard, Peter C Harris, Christiana Ruhrberg, Simon Walker-Samuel, Paul R Riley, Adrian S Woolf, Peter J Scambler, David A Long
Publikováno v:
eLife, Vol 8 (2019)
Heterogeneity of lymphatic vessels during embryogenesis is critical for organ-specific lymphatic function. Little is known about lymphatics in the developing kidney, despite their established roles in pathology of the mature organ. We performed three
Externí odkaz:
https://doaj.org/article/19f52d73e1eb45febdf317aa6d8af0b5
Autor:
Nuria Perretta‐Tejedor, Karen L. Price, Daniyal J. Jafree, Gideon Pomeranz, Maria Kolatsi‐Joannou, Carlos Martínez‐Salgado, David A. Long, Elisavet Vasilopoulou
Publikováno v:
Physiological Reports, Vol 12, Iss 13, Pp n/a-n/a (2024)
Abstract Cardiotrophin‐1 (CT‐1), a member of the interleukin (IL)‐6 cytokine family, has renoprotective effects in mouse models of acute kidney disease and tubulointerstitial fibrosis, but its role in glomerular disease is unknown. To address t
Externí odkaz:
https://doaj.org/article/1a2c45aabe1d48fa86625253236af88a
Autor:
Rukshana C Shroff, Karen L Price, Maria Kolatsi-Joannou, Alexandra F Todd, David Wells, John Deanfield, Richard J Johnson, Lesley Rees, Adrian S Woolf, David A Long
Publikováno v:
PLoS ONE, Vol 8, Iss 2, p e56273 (2013)
Cardiovascular disease (CVD) is increasingly recognised as a complication of childhood chronic kidney disease (CKD) even in the absence of diabetes and hypertension. We hypothesized that an alteration in angiopoietin-1 and -2, growth factors which re
Externí odkaz:
https://doaj.org/article/bd46648e07a1444c96185ead7275950a
Publikováno v:
PLoS ONE, Vol 6, Iss 4, p e18683 (2011)
Galectin-3 is a β-galactoside binding lectin with roles in diverse processes including proliferation, apoptosis, inflammation and fibrosis which are dependent on different domains of the molecule and subcellular distribution. Although galectin-3 is
Externí odkaz:
https://doaj.org/article/5d6d6a850e8743e5b57e7a8f2a76e7dc
Autor:
Christopher J. Lindsell, Matthew Shotwell, Kevin J. Anstrom, Scott Berry, Erica Brittain, Frank E. Harrell, Nancy Geller, Birgit Grund, Michael D. Hughes, Prasanna Jagannathan, Eric Leifer, Carlee B. Moser, Karen L. Price, Michael Proschan, Thomas Stewart, Sonia Thomas, Giota Touloumi, Lisa LaVange
Publikováno v:
Journal of Clinical and Translational Science, Vol 8 (2024)
Externí odkaz:
https://doaj.org/article/6c07a1087f8a4a55876a656f80919b45
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-7 (2021)
Abstract The efficient community spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in the current pandemic of coronavirus disease-2019 (COVID-19), which in severe and critical cases results in progressive pulmonary i
Externí odkaz:
https://doaj.org/article/d7c12f3f6bd547f080125ad5991b1a0f
Autor:
Emad A. Hindi, Craig J. Williams, Leo A. H. Zeef, Filipa M. Lopes, Katie Newman, Martha M. M. Davey, Nigel W. Hodson, Emma N. Hilton, Jennifer L. Huang, Karen L. Price, Neil A. Roberts, David A. Long, Adrian S. Woolf, Natalie J. Gardiner
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-16 (2021)
Abstract Diabetes mellitus (DM) is the leading cause of chronic kidney disease and diabetic nephropathy is widely studied. In contrast, the pathobiology of diabetic urinary bladder disease is less understood despite dysfunctional voiding being common
Externí odkaz:
https://doaj.org/article/3d05190d673047aca307800a35df1323
Publikováno v:
Australian Journal of General Practice. 52:143-148
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fefe2f238055951f3aa18acf2efc43fd
https://doi.org/10.31128/ajgp-08-22-6539
https://doi.org/10.31128/ajgp-08-22-6539
Publikováno v:
Australian Journal of General Practice. 52:150-157
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::97dfe3d63ea51df224d426e577155f82
https://doi.org/10.31128/ajgp-08-22-6540
https://doi.org/10.31128/ajgp-08-22-6540
Autor:
Charles Benson, Emmanuel Chigutsa, Amit Saxena, Paul Klekotka, Peter Chen, Gourab Datta, Ariel Kay, Josh Poorbaugh, Mark J. Mulligan, William A. Fischer, Ying Grace Li, Karen L. Price, Patricia Brown-Augsburger, Ajay Nirula, Robert J. Benschop, Nadine Rouphael, Jenny Y. Chien, Jeffrey Fill, Michael Dougan
Publikováno v:
Clinical Pharmacology and Therapeutics
Therapeutics for patients hospitalized with coronavirus disease 2019 (COVID-19) are urgently needed during the pandemic. Bamlanivimab is a potent neutralizing monoclonal antibody that blocks severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2fc98bbcb8ce46dfce4862bd9a03be5
http://europepmc.org/articles/PMC8653186
http://europepmc.org/articles/PMC8653186